McCall McPherson presents data on GLP medications showing 13% lower breast cancer risk, 19% lower lung cancer risk, and 17% lower prostate cancer risk among users. He also cites a 13% decrease in Alzheimer's dementia and predicts GLP drugs will become treatments for eating disorders.
Chapters
While everyone in the world is talking about how they cause cancer, I want you all to know the truth, which is there's a 13% reduction in breast cancer risk, 19% in lung cancer, 17% in prostate cancer, 16% in colorectal cancer, and a 6% reduction in pancreatic cancer. Not only that, if someone is on a GLP and they have already had cancer, their risk of dying from cancer is still statistically significantly lower if they're on a GLP compared to people who are not. We also looked at 175 outcomes in all aspects of health of people on a GLP, and it showed a 13% reduction in Alzheimer's dementia, 17% reduction in schizophrenia and psychosis, an 18% reduction in the incidence of bulimia, Mark my words, these medications will be the future treatment of many eating disorders. And I know that sounds crazy. Watch, because it will happen.